Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Diamantis I. Tsilimigras

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3676-9263; OpenAlex author ID A5052875638. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2019: 5 papers · 2020: 3 papers · 2021: 3 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 3 papers

Papers 17

  1. Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.surg.2024.08.027↗
  2. Response to letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma". Co-author DOI 10.1016/j.surg.2024.10.006↗
  3. Quality Score Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Trends, Racial Disparities, and Impact on Outcomes. Co-author DOI 10.6004/jnccn.2024.7089↗
  4. Association between social determinants of health and delayed postoperative adjuvant therapy among patients undergoing resection of pancreatic cancer. Co-author DOI 10.1002/jso.27571↗
  5. Implications of intensive care unit admissions among medicare beneficiaries following resection of pancreatic cancer. Co-author DOI 10.1002/jso.26710↗
  6. Patterns of health care utilization among Medicare beneficiaries diagnosed with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2021.10.027↗
  7. Sex-based differences in time to surgical care among pancreatic cancer patients: A national study of Medicare beneficiaries. Co-author DOI 10.1002/jso.26266↗
  8. Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer. Co-author DOI 10.1016/j.hpb.2020.08.002↗
  9. Impact of Race/Ethnicity and County-Level Vulnerability on Receipt of Surgery Among Older Medicare Beneficiaries With the Diagnosis of Early Pancreatic Cancer. Co-author DOI 10.1245/s10434-021-09911-1↗
  10. Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.25861↗
  11. Variations in Healthcare Expenditures Among Medicare Beneficiaries Undergoing Resection of Pancreatic Cancer. Co-author DOI 10.1007/s11605-020-04660-0↗
  12. The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review. Co-author DOI 10.1016/j.ejso.2020.05.017↗
  13. Hospice utilization among Medicare beneficiaries dying from pancreatic cancer. Co-author DOI 10.1002/jso.25623↗
  14. Identifying the Optimal Lymph Node Number to Resect for Pancreatic Cancer: An Unsolved Problem. First author DOI 10.1016/j.jamcollsurg.2019.03.004↗
  15. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07261-7↗
  16. ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07436-2↗
  17. The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery. Co-author DOI 10.1245/s10434-019-07677-1↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy Michael Pawlik · 16 shared papers, 2019–2025 · strength 3.04
  2. J. Madison Hyer · 9 shared papers, 2019–2022 · strength 1.27
  3. Aslam M. Ejaz · 9 shared papers, 2019–2024 · strength 1.15
  4. Mary E. Dillhoff · 6 shared papers, 2019–2024 · strength 0.78
  5. Jordan M. Cloyd · 6 shared papers, 2019–2022 · strength 0.69
  6. Anghela Z. Paredes · 5 shared papers, 2019–2021 · strength 0.54
  7. Allan Tsung · 4 shared papers, 2019–2022 · strength 0.47
  8. Dimitrios Moris · 3 shared papers, 2019–2020 · strength 0.38
  9. Anne M. Noonan · 1 shared paper, 2025 · strength 0.33
  10. Adrián Díaz · 2 shared papers, 2021 · strength 0.31
  11. Rosevine A. Azap · 2 shared papers, 2021 · strength 0.31
  12. Daniel R. Rice · 1 shared paper, 2022 · strength 0.22
  13. Yutaka Endo · 1 shared paper, 2024 · strength 0.21
  14. Muhammad Muntazir Mehdi Khan · 1 shared paper, 2024 · strength 0.21
  15. Muhammad Musaab Munir · 1 shared paper, 2024 · strength 0.21
  16. Zayed Rashid · 1 shared paper, 2024 · strength 0.21
  17. Rittal Mehta · 2 shared papers, 2019 · strength 0.18
  18. Djhenne M. Dalmacy · 1 shared paper, 2022 · strength 0.16
  19. Alessandro Paro · 1 shared paper, 2022 · strength 0.16
  20. Pabos Charalambous · 1 shared paper, 2020 · strength 0.12
  21. Athanasios S. Petrou · 1 shared paper, 2020 · strength 0.12
  22. Dimitrios Oikonomou · 1 shared paper, 2020 · strength 0.12
  23. Nikolaos Dimitrokallis · 1 shared paper, 2020 · strength 0.12
  24. Alexandros Papalampros · 1 shared paper, 2020 · strength 0.12
  25. Georgia Sofia Karachaliou · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.